Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

834 ARTÍCULOS , VIENDO DEL 541 AL 555

Social Cognition in Parkinson's Disease after Focused Ultrasound Subthalamotomy: A Controlled Study

Guida P, Martínez-Fernández R, Máñez-Miró JU, Del Álamo M, Foffani G, Fernández-Rodríguez B, Monje MHG, Obeso I, Obeso JA, Gasca-Salas C.

Mov Disord. 2024 Oct;39(10):1763-1772. doi: 10.1002/mds.29945. Epub 2024 Aug 14.

Effect of robot-assisted gait training on motor dysfunction in Parkinson's patients:A systematic review and meta-analysis

Jiang X, Zhou J, Chen Q, Xu Q, Wang S, Yuan L, Zhang D, Bi H, Li H.

J Back Musculoskelet Rehabil. 2024;37(2):253-268. doi: 10.3233/BMR-220395.

Bidirectional Interplay between Deep Brain Stimulation and Cognition in Parkinson's Disease: A Systematic Review

Sisodia V, Malekzadeh A, Verwijk E, Schuurman PR, de Bie RMA, Swinnen BEKS.

Mov Disord. 2024 May;39(5):910-915. doi: 10.1002/mds.29772. Epub 2024 Mar 1.

The role of AI and machine learning in the diagnosis of Parkinson's disease and atypical parkinsonisms

Dennis AP, Strafella AP.

Parkinsonism Relat Disord. 2024 Sep;126:106986. doi: 10.1016/j.parkreldis.2024.106986. Epub 2024 May 3.

The identification of cognitive impairment in Parkinson's disease using biofluids, neuroimaging, and artificial intelligence

Dennis AP, Strafella AP.

Front Neurosci. 2024 Sep 26;18:1446878. doi: 10.3389/fnins.2024.1446878. eCollection 2024.

Randomized controlled trial of intermittent hypoxia in Parkinson's disease: study rationale and protocol

Janssen Daalen JM, Meinders MJ, Mathur S, van Hees HWH, Ainslie PN, Thijssen DHJ, Bloem BR.

BMC Neurol. 2024 Jun 22;24(1):212. doi: 10.1186/s12883-024-03702-3.

Buspirone and Zolmitriptan Combination for Dyskinesia: A Randomized, Controlled, Crossover Study

LeWitt PA, Stebbins GT, Christensen KV, Tan R, Pretorius A, Thomsen M.

Mov Disord. 2024 Mar;39(3):613-618. doi: 10.1002/mds.29713. Epub 2024 Feb 5.

A Randomized Phase 2 KINETIC Trial Evaluating SAGE-324/BIIB124 in Individuals with Essential Tremor

Elble RJ, Ondo WG, Lyons KE, Qin M, Garafola S, Hersh B, Lieu T, Arkilo D, Chuang R, Bankole K, Pahwa R.

Mov Disord. 2024 Apr;39(4):733-738. doi: 10.1002/mds.29731. Epub 2024 Feb 15.

Frequency of Hereditary and GBA1-Related Parkinsonism in Latin America: A Systematic Review and Meta-Analysis

Saffie Awad P, Teixeira-Dos-Santos D, Santos-Lobato BL, Camargos S, Cornejo-Olivas M, de Mello Rieder CR, Mata IF, Chaná-Cuevas P, Klein C, Schumacher Schuh AF.

Mov Disord. 2024 Jan;39(1):6-16. doi: 10.1002/mds.29614. Epub 2023 Nov 3.

A Double-Blind, Randomized, Placebo-Controlled Trial of Bumetanide in Parkinson's Disease

Damier P, Degos B, Castelonovo G, Anheim M, Benatru I, Carrière N, Colin O, Defebvre L, Deverdal M, Eusebio A, Ferrier V, Giordana C, Houeto JL, Le Dily S, Mongin M, Thiriez C, Tranchant C, Ravel D, Corvol JC, Rascol O, Ben Ari Y.

Mov Disord. 2024 Mar;39(3):618-622. doi: 10.1002/mds.29726. Epub 2024 Jan 30.

Immunomodulation as a treatment for parkinson's disease in current trials: a systematic review and meta-analysis

Vega-Angeles VT, Morales-Ruiz V, Adalid-Peralta LV.

Rev Invest Clin. 2024 Jul 18;76(3):159-169. doi: 10.24875/RIC.24000068.

Opicapone for the treatment of early wearing-off in levodopa-treated Parkinson's disease: pooled analysis of patient level data from two randomized open-label studies

Ferreira JJ, Lee JY, Ma HI, Jeon B, Poewe W, Antonini A, Stocchi F, Rodrigues DM, Fonseca MM, Castilla-Fernández G, Holenz J, Rocha JF, Rascol O; ADOPTION study investigators.

J Neurol. 2024 Oct;271(10):6729-6738. doi: 10.1007/s00415-024-12614-8. Epub 2024 Aug 21.

Assessing Changes in Motor Function and Mobility in Individuals with Parkinson's Disease After 12 Sessions of Patient-Specific Adaptive Dynamic Cycling

Kim Y, Smith BE, Shigo L, Shaikh AG, Loparo KA, Ridgel AL.

Sensors (Basel). 2024 Nov 19;24(22):7364. doi: 10.3390/s24227364.

Triheptanoin Did Not Show Benefit versus Placebo for the Treatment of Paroxysmal Movement Disorders in Glut1 Deficiency Syndrome: Results of a Randomized Phase 3 Study

De Giorgis V, Bhatia KP, Boespflug-Tanguy O, Gras D, Marina AD, Desurkar A, Toledo M, Miller I, Rotstein M, Schneider SA, Tarquinio DC, Weber Y, Brandabur M, Mayhew J, Koutsoukos T, De Vivo DC.

Mov Disord. 2024 Aug;39(8):1386-1396. doi: 10.1002/mds.29822. Epub 2024 May 9.

The Effect of taVNS at 25 Hz and 100 Hz on Parkinson's Disease Gait-A Randomized Motion Sensor Study

van Midden V, Simončič U, Pirtošek Z, Kojović M.

Mov Disord. 2024 Aug;39(8):1375-1385. doi: 10.1002/mds.29826. Epub 2024 May 17.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias